intelliseed trials in china, page-5

... this may interest your concerns in this thread - from the annual report .....
.... Press Commentary ....
.
Shareholders will be aware of the Fairfax press articles back in April this year making allegations
about our DataTraceDNA technology and our dealing with a major European pharmaceutical
company. We reiterate the comments made in the ASX release of 15 April 2013 in which we stated
that the products supplied to the European Pharmaceutical Company were appropriate for their
intended application and categorically deny the allegations made.
We also now have available spectral and chemical analysis from a reputable and independent
laboratory confirming that product supplied to our client was not material bought off the shelf from
China, rebranded and on-sold as a security product to our client as alleged.
DataTrace DNA has not lost a customer in the period following publication of the Fairfax press
articles in April, nor has it received any demands from any customer.
We stand behind the DataTraceDNA technology as a world-class technology.
...
... ... ende ...
...
...